Corteva (CTVA) Stock Price Increased by UBS to $90, Average Target at $76.41

UBS has increased its price target for Corteva (CTVA) to $90, maintaining a Buy recommendation. The decision reflects UBS's positive outlook on Corteva's growth and profitability. The average target price for CTVA is $76.41, with a high estimate of $92.00 and a low estimate of $60.00. The average target implies a downside of 0.05% from the current price of $76.45.

UBS Group has increased its price target for Corteva (CTVA) to $90, maintaining a "Buy" recommendation. The decision reflects UBS's positive outlook on Corteva's growth and profitability. The brokerage's new target price indicates a potential upside of 18.13% from the stock's previous close, according to Benzinga [1].

The average target price for CTVA is $76.41, with a high estimate of $92.00 and a low estimate of $60.00. This average target implies a downside of 0.05% from the current price of $76.45. The new target price is in line with other analyst ratings, with Oppenheimer, Jefferies, BMO Capital Markets, Citigroup, and Argus all expressing positive views on the stock [1].

Corteva's recent earnings report highlighted strong financial performance. The company reported $1.13 earnings per share (EPS) for the quarter, surpassing analysts' consensus estimates by $0.25. The company's quarterly revenue was down 1.7% compared to the same quarter last year, but it delivered 1% price/mix growth during the quarter, demonstrating a gradual end-market recovery [2].

Institutional investors and hedge funds have also shown confidence in Corteva. Capital World Investors, Nuveen LLC, Independent Franchise Partners LLP, Norges Bank, and JPMorgan Chase & Co. have all increased their holdings in the company's stock [1].

Looking ahead, Corteva's growth prospects are bolstered by a positive ethanol policy in Brazil, which is expected to increase demand for corn. The company's plans to release 500 new seed products this year and its cost-saving initiatives are also likely to drive growth [2].

UBS's decision to raise its price target for Corteva reflects a positive outlook on the company's growth and profitability. The new target price indicates a potential upside of 18.13% from the stock's previous close, making it an attractive investment opportunity for investors.

References:
[1] https://www.marketbeat.com/instant-alerts/ubs-group-increases-corteva-nysectva-price-target-to-9000-2025-07-09/
[2] https://seekingalpha.com/article/4799939-corteva-q2-preview-potential-benefit-from-positive-biofuel-policy-in-brazil